AIDS in Developing Countries

AIDS in Developing Countries | U.S. Pharmaceutical Companies and the U.S. Government Have Blocked the Availability of AIDS Drugs in Developing Countries

Robert Weissman is editor of Multinational Monitor magazine and codirector of Essential Action, a corporate accountability group. He also is coauthor of Corporate Predators: The Hunt for Megaprofits and the Attack on Democracy.

Summary: The United States government and U.S. pharmaceutical companies have actively opposed efforts by developing countries to make life-saving AIDS drugs more affordable and available in their countries. The efforts of these developing countries involve compulsory licensing and parallel importing, two ways of making AIDS drugs...

[The entire page is 2615 words long]

Join eNotes

The above is a free excerpt. Get total access to this content with the: